Literature DB >> 6174439

Use of hybridoma-resident variant cell lines to study H-2Db/FMR-specific cytotoxic T cells.

J M Chapdelaine, T V Rajan, S G Nathenson, F Lilly.   

Abstract

An H-2Db heterozygous tumor cell line and a variant subclone bearing a mutant gene product were used to analyze the H-2Db specificity of cytotoxic T lymphocytes (CTL) generated during a Moloney murine sarcoma virus (MSV) infection. When the mutant cells were used as targets for MSV-specific CTL, the amount of cell lysis, compared with that seen with the nonmutant parental cells, was drastically decreased. However, cells of the mutant clones remained susceptible to allogeneic CTL specific for the nonmutant H-2Db molecule. The mutant cells also did not differ from the parent cells in their level of viral antigen expression. Biochemically the parental and mutant molecules were similar but not identical. The data indicate that minor alterations of the H-2 antigens caused by somatic mutation may prevent virus-infected cells from being recognized as targets by CTL.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174439     DOI: 10.1007/BF00373323

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  15 in total

1.  H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.

Authors:  E Gomard; V Duprez; Y Henin; J P Levy
Journal:  Nature       Date:  1976-04-22       Impact factor: 49.962

2.  Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.

Authors:  F Plata; E Gomard; J C Leclerc; J P Levy
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

3.  Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.

Authors:  J P Glynn; J L McCoy; A Fefer
Journal:  Cancer Res       Date:  1968-03       Impact factor: 12.701

4.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

5.  Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo.

Authors:  F Plata; B Sordat
Journal:  Int J Cancer       Date:  1977-02-15       Impact factor: 7.396

6.  Biochemical studies on the H-2K antigens of the MHC mutants bm3 and bm11.

Authors:  B M Ewenstein; H Uehara; T Nisizawa; R W Melvold; H I Kohn; S G Nathenson
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

7.  Structural differences between parent and mutant H-2K glycoproteins from two H-2K gene mutants: b6.c-h-2ba (Hzl) and B6-H-2bd (M505).

Authors:  J L Brown; S G Nathenson
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.

Authors:  F Plata; V Jongeneel; J C Cerottini; K T Brunner
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

9.  Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes.

Authors:  J M Chapdelaine; F Plata; F Lilly
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

10.  Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.

Authors:  H A Freedman; F Lilly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  4 in total

1.  Immunoselection of structural H-2Kb variants: use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant.

Authors:  J M Sheil; M J Bevan; L A Sherman
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 2.  Somatic cell variants of the murine major histocompatibility complex.

Authors:  R A Zeff; P A Kumar; H Mashimo; M Nakagawa; B McCue; F Borriello; K Kesari; J Geliebter; S Hemmi; G Pfaffenbach
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

3.  Selection of cell lines resistant to anti-transferrin receptor antibody: evidence for a mutation in transferrin receptor.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

4.  Epitopes on H-2Dd somatic cell mutants recognized by cytotoxic T cells.

Authors:  T A Potter; M A Palladino; D B Wilson; T V Rajan
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.